From Slowly Progressive Amnesic Syndrome to Rapidly Progressive Alzheimer Disease

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 3, 1998, Pages 251-253

  Caselli, R J ^a   Couce, M E ^a   Osborne, D ^a   Deen, H G ^b   Parisi, J P ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alzheimer disease ; Amnesic syndrome ; Rapidly progressive dementia

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGICAL ASPECT; SYNDROME;

ALZHEIMER DISEASE; AMNESIA; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SYNDROME;

EID: 0032150578     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Armstrong TP, Hansen LA, Salmon DP, et al. Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease. Neurology 991 ;41:1178-80.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
3. Doody RS, Lynn P, Massman P. A calculated measure to predict the rate of progression in Alzheimer's disease. Neurology 1995a;45(suppl): A195.
4. Doody RS, Massman P, Mahurin R, Law S. Positive and negative neuropsychiatrie features in Alzheimer's disease. JNeuropsychiatry Clin Neurosci 1995e;7:54-60.
5. Galasko D, Gould R, Abramson I, et al. Rate of cognitive decline in Alzheimer's disease: relationship to clinical and biological factors. Neurology 1995;45(suppl):A195-6.
6. Jeste D, Wragg RE, Salmon DP, Harris MJ, Thal LJ. Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry 1992;149:184-9.
7. Katzman R, Brown T, Thai LJ, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neural 1988;24:384-9.
8. Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Five 1987;62:281-8.
9. Lezak MD. Neuropsychological assessment, 2nd ed. New York: Oxford University Press, 1983.
10. Lopez O, Claasen D, Boiler F. Alzheimer's disease, cerebral amyloid angiopathy, and dementia of acute onset. Aging 1991;3:171-5.
11. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985;35:453-61.
12. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-8.
13. Saunders AM, Hulette C, Welsh-Bohmer KA, et al. Specificity, sensititvity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:9.
14. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
15. Stern Y, Liu XH, Tsai WY, Albert M, Brandt J. Growth curve models of the progression of Alzheimer's disease. Neurology 1995;45(suppl):A195.
16. StemY, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurololgv 1987;37:1649-53.